Arkolith/Insider Trading/PTGX/Form 4

Molina Arturo MD

Chief Medical OfficerProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Jan 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.9M
Net Open-Market Flow
-$1.9M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)5K$8.04$40K89K
Jan 27, 2026Sell(S)5K$82.00$410K84K
Jan 26, 2026Option exercise(M)5K$8.04$40K89K
Jan 26, 2026Sell(S)5K$82.28$411K84K
Jan 23, 2026Sell(S)13K$82.42$1.1M84K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 27, 2026Option exercise(M)5K—$066K
Jan 26, 2026Option exercise(M)5K—$071K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-007127) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML